Vav1 promotes T cell cycle progression by linking TCR/CD28 costimulation to FOXO1 and p27kip1 expression

Journal of Immunology

Volumn 177, Issue 8, 2006, Pages 5024-5031

  Charvet, Céline ^a,d   Canonigo, Ann Janette ^a   Bécart, Stéphane ^a   Maurert, Ulrich ^a,e   Miletic, Ana V ^b   Swat, Wojciech ^b   Deckert, Marcel ^c   Altman, Amnon ^a,f  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b USA   (United States)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e UNIVERSITY OF FREIBURG   (Germany)

^f NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CYCLIN D3; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYTOKINE; INTERLEUKIN 2; PROTEIN 14 3 3; PROTEIN 14 3 3TAU; PROTEIN KINASE B; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FKHR; UNCLASSIFIED DRUG; VAV PROTEIN; VAV1 PROTEIN; VAV3 PROTEIN;

ANIMAL CELL; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOPLASM; CYTOSKELETON; DOWN REGULATION; GENETIC TRANSCRIPTION; IMMUNOSTIMULATION; LYMPHOBLAST; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE ACTIVATION; WILD TYPE;

EID: 33749516648     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.8.5024     Document Type: Article

References (36)

1. Bustelo, X. R. 2002. Regulation of Vav proteins by intramolecular events. Front Biosci. 7: D24-D30.
2. Tybulewicz, V. L., L. Ardouin, A. Prisco, and L. F. Reynolds. 2003. Vav1: a key signal transducer downstream of the TCR. Immunol. Rev. 192: 42-52.
3. Raab, M., S. Pfister, and C. E. Rudd. 2001. CD28 signaling via VAV/SLP-76 adaptors. Regulation of cytokine transcription independent of TCR ligation. Immunity 15: 921-933.
4. Charvet, C., A. J. Canonigo, D. D. Billadeau, and A. Altman. 2005. Membrane localization and function of Vav3 in T cells depend on its association with the adapter SLP-76. J. Biol. Chem. 280: 15289-15299.
5. Costello, P. S., A. E. Walters, P. J. Mee, M. Turner, L. F. Reynolds, A. Prisco, N. Sarner, R. Zamoyska, and V. L. Tybulewicz. 1999. The Rho-family GTP exchange factor Vav is a critical transducer of T cell receptor signals to the calcium, ERK, and NF-kappaB pathways. Proc. Natl. Acad. Sci. USA 96: 3035-3040.
6. Tarakhovsky, A., M. Turner, S. Schaal, P. J. Mee, L. P. Duddy, K. Rajewsky, and V. L. Tybulewicz. 1995. Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. Nature 374: 467-470.
7. Zhang, R., F. W. Alt, L. Davidson, S. H. Orkin, and W. Swat. 1995. Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene. Nature 374: 470-473.
8. + thymocytes. Nature 374: 474-477.
9. Fujikawa, K., A. V. Miletic, F. W. Alt, R. Faccio, T. Brown, J. Hoog, J. Fredericks, S. Nishi, S. Mildiner, S. L. Moores, et al. 2003. Vav1/2/3-null mice define an essential role for Vav family proteins in lymphocyte development and activation but a differential requirement in MAPK signaling in T and B cells. J. Exp. Med. 198: 1595-1608.
10. Reynolds, L. F., L. A. Smyth, T. Norton, N. Freshney, J. Downward, D. Kioussis, and V. L. Tybulewicz. 2002. Vav1 transduces T cell receptor signals to the activation of phospholipase C-γ1 via phosphoinositide 3-kinase-dependent and -independent pathways. J. Exp. Med. 195: 1103-1114.
11. Inabe, K., M. Ishiai, A. M. Scharenberg, N. Freshney, J. Downward, and T. Kurosaki. 2002. Vav3 modulates B cell receptor responses by regulating phosphoinositide 3-kinase activation. J. Exp. Med. 195: 189-200.
12. Coffer, P. J., and B. M. Burgering. 2004. Forkhead-box transcription factors and their role in the immune system. Nat. Rev. Immunol. 4: 889-899.
13. Brunet, A., A. Bonni, M. J. Zigmond, M. Z. Lin, P. Juo, L. S. Hu, M. J. Anderson, K. C. Arden, J. Blenis, and M. E. Greenberg. 1999. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96: 857-868.
14. Yusuf, L. X. Zhu, M. G. Kharas, J. Chen, and D. A. Fruman. 2004. Optimal B-cell proliferation requires phosphoinositide 3-kinase-dependent inactivation of FOXO transcription factors. Blood 104: 784-787.
15. Fabre, S., V. Lang, J. Harriague, A. Jobart, T. G. Unterman, A. Trautmann, and G. Bismuth. 2005. Stable activation of phosphatidylinositol 3-kinase in the T cell immunological synapse stimulates Akt signaling to FoxOl nuclear exclusion and cell growth control. J. Immunol. 174: 4161-4171.
16. Birkenkamp, K. U., and P. J. Coffer. 2003. FOXO transcription factors as regulators of immune homeostasis: molecules to die for? J. Immunol. 171: 1623-1629.
17. Hosaka, T., W. H. Biggs, 3rd, D. Tieu, A. D. Boyer, N. M. Varki, W. K. Cavenee, and K. C. Arden. 2004. Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification. Proc. Natl. Acad. Sci. USA 101: 2975-2980.
18. Lin, L., J. D. Hron, and S. L. Peng. 2004. Regulation of NF-κB, Th activation, and autoinflammation by the forkhead transcription factor Foxo3a. Immunity 21: 203-213.
19. Tanaka, Y., T. So, S. Lebedeva, M. Croft, and A. Altman. 2005. Impaired IL-4 and c-Maf expression and enhanced Th1-cell development in Vav1-deficient mice. Blood 106: 1286-1295.
20. Droin, N. M., M. J. Pinkoski, E. Dejardin, and D. R. Green. 2003. Egr family members regulate nonlymphoid expression of Fas ligand, TRAIL, and tumor necrosis factor during immune responses. Mol. Cell Biol. 23: 7638-7647.
21. Fruman, D. A. 2004. Phosphoinositide 3-kinase and its targets in B-cell and T-cell signaling. Curr. Opin. Immunol. 16: 314-320.
22. Vigorito, E., G. Bardi, J. Glassford, E. W. Lam, E. Clayton, and M. Turner. 2004. Vav-dependent and vav-independent phosphatidylinositol 3-kinase activation in murine B cells determined by the nature of the stimulus. J. Immunol. 173: 3209-3214.
23. Salojin, K. V., J. Zhang, and T. L. Delovitch. 1999. TCR and CD28 are coupled via ZAP-70 to the activation of the Vav/Rac-1- /PAK-1/p38 MAPK signaling pathway. J. Immunol. 163: 844-853.
24. Charvet, C., I. Alberti, F. Luciano, A. Jacquel, A. Bernard, P. Auberger, and M. Deckert. 2003. Proteolytic regulation of Forkhead transcription factor FOXO3a by caspase-3-like proteases. Oncogene 22: 4557-4568.
25. Dijkers, P. F., R. H. Medema, C. Pals, L. Banerji, N. S. Thomas, E. W. Lam, B. M. Burgering, J. A. Raaijmakers, J. W. Lammers, L. Koenderman, and P. J. Coffer. 2000. Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27KIP1. Mol. Cell Biol. 20: 9138-9148.
26. kip1. Nature 404: 782-787.
27. Kip1 and Bim in response to IL-2. J. Immunol. 168: 5024-5031.
28. Evans, G. A., O. M. Howard, R. Erwin, and W. L. Farrar. 1993. Interleukin-2 induces tyrosine phosphorylation of the vav proto-oncogene product in human T cells: lack of requirement for the tyrosine kinase lck. Biochem. J. 294 (Pt 2): 339-342.
29. Fischer, K. D., Y. Y. Kong, H. Nishina, K. Tedford, L. E. Marengere, I. Kozieradzki, T. Sasaki, M. Starr, G. Chan, S. Gardener, et al. 1998. Vav is a regulator of cytoskeletal reorganization mediated by the T- cell receptor. Curr. Biol. 8: 554-562.
30. Burgering, B. M., and G. J. Kops. 2002. Cell cycle and death control: long live Forkheads. Trends Biochem. Sci. 27: 352-360.
31. Glassford, J., M. Holman, L. Banerji, E. Clayton, G. G. Klaus, M. Turner, and E. W. Lam. 2001. Vav is required for cyclin D2 induction and proliferation of mouse B lymphocytes activated via the antigen Receptor. J. Biol. Chem. 276: 41040-41048.
32. Rodriguez-Viciana, P., P. H. Warne, R. Dhand, B. Vanhaesebroeck, I. Gout, M. J. Fry, M. D. Waterfield, and J. Downward. 1994. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 370: 527-532.
33. Brunet, A., F. Kanai, J. Stehn, J. Xu, D. Sarbassova, J. V. Frangioni, S. N. Dalal, J. A. DeCaprio, M. E. Greenberg, and M. B. Yaffe. 2002. 14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport. J. Cell Biol. 156: 817-828.
34. Dijkers, P. F., R. H. Medema, J. W. Lammers, L. Koenderman, and P. J. Coffer. 2000. Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1. Curr. Biol. 10: 1201-1204.
35. kip1 expression in human peripheral T lymphocytes. Eur. J. Immunol. 29: 789-798.
36. kip1 in BALB/c 3T3 cells. Mol. Biol. Cell 9: 2081-2092.